Less than two weeks after posting a scathing Form 483 filing, the FDA slammed Chinese API maker Sichuan Deebio Pharmaceuticals with a warning letter (PDF) citing “significant deviations” in its ...

China, the world leader in the API industry, is on a consolidation path and quality drive to raise its own benchmarks in the global turf, that too with no qualms about the tightening quality norms ...

The Active Pharmaceutical Ingredient (API) is the most important part of any drug. The API, as the name would suggest, is the chemical part of any capsule or tablet that works on the disease condition ...

Integrated Service Is on the Horizon Due to Multinational CROs and Consolidation of Firms The Chinese outsourcing industry is playing an increasingly important role in today’s global pharmaceutical ...

BEIJING (Reuters) -Chinese artificial intelligence (AI) companies are moving swiftly to attract users of OpenAI's technology, following reports the U.S. firm plans to restrict access in China and ...

OpenAI recently surprised users by announcing that, starting July 9, 2024, it will cease providing API services to China and other regions, including Hong Kong. This abrupt decision spells trouble for ...